Flow cytometry is a technique for analysing single cells in solution quickly and with multiple parameters. Flow cytometers use lasers as light sources to generate scattered and fluorescent light signals, which are detected by photodiodes or photomultiplier tubes. These signals are transformed to electrical signals, which are then processed by a computer and written to a standardised format data file (.fcs). Based on their fluorescent or light-scattering features, cell populations can be studied and/or isolated.
Flow cytometry makes use of a range of fluorescent reagents. Fluorescently conjugated antibodies, DNA binding dyes, viability dyes, ion indicator dyes, and fluorescent expression proteins are examples of these.
Flow cytometry is a versatile technology used in immunology, molecular biology, bacteriology, virology, cancer biology, and infectious disease surveillance. Over the last 30 years, it has advanced dramatically, allowing for unparalleled detail in studies of the immune system and other aspects of cell biology.
The major factors driving the growth of the flow cytometry market are the technological advancements in flow cytometers, increasing adoption of flow cytometry techniques in research activities and clinical trials, the growing focus on immunology and immuno-oncology research, high incidence and prevalence of HIV-AIDS and cancer, and availability of novel application-specific flow cytometry products.The global Flow Cytometry Market is projected to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018, at a CAGR of 8.1%Recent Developments :-In 2018, Becton, Dickinson and Company (US) launched BD FACSymphony S6 High Parameter Cell Sorter.In 2018, Agilent Technologies, Inc. (US) entered into an agreement to acquire ACEA Biosciences Inc. (US) to expand its global revenue base, product portfolio, and strengthen its market share.In 2018, Merck KGaA (Germany) launched the CellStream benchtop flow cytometer system.Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584The growing market penetration in emerging countries, growth in stem cell research, adoption of recombinant DNA technology for antibody production, and evolution of tandem flow cytometry technologies are expected to present a wide range of growth opportunities for market players.The flow cytometry market is segmented on the basis of products and services into reagents and consumables, instruments, services, software, and accessories.
The reagents and consumables segment is expected to command the largest share of the global flow cytometry market in 2018.
Factors such as the development and commercialization of high-quality application-specific reagents and assays and the continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities) are expected to drive the growth of the reagents and consumables market in the coming years.Geographical Analysis:- The market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of APAC), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa.
North America is expected to account for the largest share of the global flow cytometry market in 2018.Read more ( Flow cytometry market ): https://www.marketsandmarkets.com/PressReleases/flow-cytometry.aspMajor Key players :-The major players operating in the flow cytometry market are Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US) and Apogee Flow Systems Ltd. (UK).
About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.
